Melphalan 140 mg/m2 is Safe and Effective for Frail and Older Multiple Myeloma Patients With Comparable Rates of Minimal Residual Disease Negativity

作者：Jeries Kort, Nikolas Naleid, Frank Oley, James John Ignatz-Hoover, Seunghee Park Margevicius, Pingfu Fu, Ehsan Malek, Brenda Cooper · 发表于：Clinical Lymphoma Myeloma & Leukemia · 年份：2025 · DOI：10.1016/j.clml.2025.02.004 · 被引用次数：3 · 研究领域：Multiple Myeloma Research and Treatments、Acute Myeloid Leukemia Research、Bioactive Compounds in Plants